IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BVF Inc

Q2 2024 Holdings

Filed 2024-08-14 | 60 holdings | $3.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Moonlake Immunotherapeutics(MLTX)CLASS A ORD61559X104$956.4M21,751,28426.8%
Revolution Medicines Inc(RVMD)COM76155X100$232.1M5,981,2126.5%
Kymera Therapeutics Inc(KYMR)COM501575104$154.1M5,161,8014.3%
Ionis Pharmaceuticals Inc(IONS)COM462222100$151.9M3,186,3764.3%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$149.4M4,370,0244.2%
GH Research PLC(GHRS)ORDINARY SHARESG3855L106$121.3M10,400,1583.4%
Protagonist Therapeutics Inc(PTGX)COM74366E102$115.0M3,319,2903.2%
Cullinan Therapeutics Inc(CGEM)COM230031106$100.3M5,750,6832.8%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$98.9M9,135,8932.8%
Structure Therapeutics Inc(GPCR)SPONSORED ADS86366E106$97.7M2,487,7622.7%
Xoma Corp del(XOMA)COM NEW98419J206$86.1M3,633,7432.4%
Kura Oncology Inc(KURA)COM50127T109$84.0M4,082,0372.4%
4D Molecular Therapeutics in(FDMT)COM35104E100$82.3M3,922,4132.3%
Axsome Therapeutics Inc(AXSM)COM05464T104$76.9M955,0002.2%
CG Oncology Inc(CGON)COM156944100$76.3M2,417,8852.1%
Merus N VCOMN5749R100$75.7M1,279,0492.1%
AC Immune SA(ACIU)SHSH00263105$75.2M18,834,9362.1%
Tyra Biosciences Inc(TYRA)COM90240B106$74.5M4,661,1942.1%
89Bio Inc(ETNBGBP)COM282559103$60.6M7,568,4791.7%
Celcuity Inc(CELC)COM15102K100$56.8M3,466,0001.6%
Third Harmonic BIO Inc(THRD)COM88427A107$56.8M4,365,9331.6%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$51.3M1,190,1071.4%
Zymeworks Inc(ZYME)COM98985Y108$50.0M5,870,0001.4%
Essa Pharma Inc(EPIEUR)COM NEW29668H708$46.0M8,748,6291.3%
Ideaya Biosciences Inc(IDYA)COM45166A102$40.8M1,162,3061.1%
Galapagos NV(GLPG)SPON ADR36315X101$38.9M1,569,4221.1%
Annexon Inc(ANNX)COM03589W102$34.3M7,000,0001.0%
Repare Therapeutics Inc(RPTX)COM760273102$34.1M10,333,6001.0%
Foghorn Therapeutics Inc(FHTX)COM344174107$30.5M5,302,0000.9%
Calliditas Therapeutics ABSPONSERED ADS13124Q106$29.2M750,0000.8%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$29.2M1,521,9480.8%
Roivant Sciences LTD(ROIV)SHSG76279101$29.0M2,742,4090.8%
Engene Holdings Inc(ENGN)COM29286M105$21.2M2,251,0370.6%
Janux Therapeutics Inc(JANX)COM47103J105$18.5M441,5280.5%
Tscan Therapeutics Inc(TCRX)COM89854M101$17.5M2,989,4740.5%
Eledon Pharmaceuticals Inc(ELDN)COM28617K101$16.6M6,293,2820.5%
Allakos Inc(ALLKGUSD)COM01671P100$16.6M16,552,4170.5%
Immunic Inc(IMUX)COM4525EP101$9.9M8,902,9720.3%
Ikena Oncology IncCOM45175G108$7.9M4,769,1640.2%
Vigil Neuroscience Inc(VIGL)COM92673K108$7.3M1,813,6330.2%
Vistagen Therapeutics Inc(VTGN)COM92840H400$7.0M2,000,0000.2%
Cytomx Therapeutics Inc(CTMX)COM23284F105$6.4M5,228,4610.2%
Elevation Oncology IncCOM28623U101$6.2M2,312,2000.2%
Verastem Inc(VSTM)COM NEW92337C203$5.0M1,685,2190.1%
Cidara Therapeutics Inc(CDTX)COM NEW171757206$4.1M343,0550.1%
Verve Therapeutics IncCOM92539P101$3.2M650,0000.1%
Molecular Partners AG(MOLN)ADS60853G106$3.2M443,2210.1%
Ovid Therapeutics Inc(OVID)COM690469101$3.0M3,853,8180.1%
SAB Biotherapeutics Inc(SABS)COM NEW78397T202$2.8M917,8260.1%
Glycomimetics Inc(GLYCEUR)COM38000Q102$2.7M9,544,2620.1%
Page 1 of 2Next